| Bioactivity | Mibenratide TFA, a small cyclic peptide, is an adrenergic β1 receptor antagonist. Mibenratide TFA can be used for heart failure research[1]. | ||||||
| Name | Mibenratide TFA | ||||||
| Sequence | Ala-Arg-Arg-Cys-Tyr-Asn-Asp-Pro-Lys-Cys-Ser-Asp-Phe-Val-Gln-Ala-Asp-Glu (Disulfide bridge:Cys4-Cys10) | ||||||
| Shortening | ARRCYNDPKCSDFVQADE (Disulfide bridge:Cys4-Cys10) | ||||||
| Formula | C87H129N27O30S2.C2HF3O2 | ||||||
| Molar Mass | 2211.27 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||
| Reference | [1]. Shubhda Dev, et al. Molecular docking analysis of natriuretic peptide receptor-c towards the design of potential atrial fibrillation inhibitors. 2320-7418. |
Mibenratide TFA
CAS: F: C87H129N27O30S2.C2HF3O2 W: 2211.27
Mibenratide TFA, a small cyclic peptide, is an adrenergic β1 receptor antagonist. Mibenratide TFA can be used for heart
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.